Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dimenhydrinate combinations vs dimenhydrinate alone for prevention of postoperative nausea and vomiting after cataract surgery
IRCT20200825048515N9Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dimenhydrinate, metoclopramide and ondansetron in postoperative nausea and vomiting (PONV) (3 arms), sponsored by Isfahan University of Medical Sciences. Started Nov 2020; status: completed.
02
Drugs
dimenhydrinatemetoclopramideondansetron
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT20200825048515N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200825048515N9.